GT Biopharma Inc. (GTBP)
NASDAQ: GTBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
GTBP stock chart
Technical analysisKey statistics
All statistics- Market cap
- $11.19M
- EPS (TTM)
- -$147.50
- Dividend yield
- None
- 52-week range
- 4.91 – 34.25
- Day range
- 6.20 – 6.47
- Volume / Avg
- 18.91K / 55.67K
- Beta
- —
- Shares outstanding
- 1.80M
52-week range
GTBP stock today
Shares of GT Biopharma (GTBP) finished lower on Oct 7 at $6.20, a drop of 2.67% or $0.17 per share, versus the S&P 500's 0.22% decline. Trading was light, with 18.91K shares changing hands, about 34% of the average daily volume. Shares are 81.9% below their 52-week high of $34.25 and 26.3% above the 52-week low of $4.91, near the bottom of the past year's range.
GTBP is up 689.8% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 724.5%. GT Biopharma has posted a net loss over the last twelve months (EPS of -$147.50), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About GT Biopharma
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
GT Biopharma peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| KPRXKiora Pharmaceuticals Inc. | 2.53 | +1.20% | $11.19M | vs GTBP |
| BLRXBioLineRx Ltd. ADR | 2.21 | -3.80% | $10.98M | vs GTBP |
| VTGNVistagen Therapeutics Inc. | 0.2471 | -1.40% | $10.97M | vs GTBP |
| MDCXMedicus Pharma Ltd. | 0.1602 | +0.63% | $11.49M | vs GTBP |
| PHIOPhio Pharmaceuticals Corp. | 0.9995 | +0.51% | $11.61M | vs GTBP |
| TOVXTheriva Biologics Inc. | 0.234 | +5.41% | $10.74M | vs GTBP |
| GDTCCytoMed Therapeutics Limited | 0.98 | +5.40% | $11.70M | vs GTBP |
| APUSApimeds Pharmaceuticals US Inc. | 7.05 | -1.12% | $10.64M | vs GTBP |
Indexes, lists and sector
GT Biopharma stock FAQ
What is GT Biopharma's stock price today?
GTBP last traded at $6.20 as of Oct 7, 4:00 PM EDT, down 2.67% on the day. Prices are delayed at least 15 minutes.
Does GT Biopharma pay a dividend?
No. GT Biopharma does not currently pay a regular cash dividend.
Has GTBP ever split its stock?
Yes. The most recent GTBP stock split was a 1-for-25 split on Sep 8, 2026, one of 3 splits on record.
What is the GTBP 52-week high?
The 52-week high for GTBP is $34.25 and the 52-week low is $4.91. The stock is currently 81.9% below its high.